Area of research
Molecular Biology · Cancer Research
Research interest
Research interests include Circular RNAs in diseases, MicroRNA in disease regulation, Cancer-related molecular mechanisms research, and Kruppel-like factors research.
Paracrine Orchestration of Tumor Microenvironment Remodeling Induced by GLO1 Potentiates Lymph Node Metastasis in Breast Cancer
Deciphering the role of <i>ELAVL1</i>: Insights from pan-cancer multiomics analyses with emphasis on nasopharyngeal carcinoma
USP5-Mediated PD-L1 deubiquitination regulates immunotherapy efficacy in melanoma
Methylation of GPRC5A promotes liver metastasis and docetaxel resistance through activating mTOR signaling pathway in triple negative breast cancer
Gut microbiota reshapes cancer immunotherapy efficacy: Mechanisms and therapeutic strategies
Single‐cell <scp>RNA</scp> sequencing elucidated the landscape of breast cancer brain metastases and identified <scp>ILF2</scp> as a potential therapeutic target
Hsa_circ_0060467 promotes breast cancer liver metastasis by complexing with eIF4A3 and sponging miR-1205
The Single‐Cell Landscape of Intratumoral Heterogeneity and The Immunosuppressive Microenvironment in Liver and Brain Metastases of Breast Cancer
The FUS/circEZH2/KLF5/ feedback loop contributes to CXCR4-induced liver metastasis of breast cancer by enhancing epithelial-mesenchymal transition
The circROBO1/KLF5/FUS feedback loop regulates the liver metastasis of breast cancer by inhibiting the selective autophagy of afadin
Turning up a new pattern: Identification of cancer-associated fibroblast-related clusters in TNBC
A Novel Pyroptosis-Associated Long Non-coding RNA Signature Predicts Prognosis and Tumor Immune Microenvironment of Patients With Breast Cancer
LGR6 Promotes Tumor Proliferation and Metastasis through Wnt/β-Catenin Signaling in Triple-Negative Breast Cancer
circFBXW7 Inhibits Malignant Progression by Sponging miR-197-3p and Encoding a 185-aa Protein in Triple-Negative Breast Cancer
CircPLK1 sponges miR-296-5p to facilitate triple-negative breast cancer progression